Scientifically referred to as ChAd-triCoV/Mac, the vaccine uses a non-replicating adenovirus vector to deliver three SARS-CoV ...

Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories. Yet, more than five decades after the discovery of the Marburg virus and ...

Afterwards, the vaccine was added to the routine immunisation programme, with the first dose administered to children at 9-12 months and the second dose at 16-24 months. With the infections being very ...

The two-dose measles mumps and rubella (MMR) vaccine is widely available, with the first dose recommended for children between the ages of 12 and 15 months and the second dose recommended between ...

Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China The modified vaccinia virus Ankara (MVA) is approved for use as a smallpox and monkeypox virus vaccine and was ...

This rapid adaptation means that "an H5N1 vaccine made (for an earlier strain) will have less efficacy," said Colby T. Ford,'14, '15 M.S., '18 Ph.D., now a visiting scholar in data science at UNC ...

Clinical trials to test vaccine against Alzheimer's-promoting tau protein Date: April 23, 2025 Source: University of New Mexico Health Sciences Center Summary: Researchers hope to launch human ...

The vaccine, based on a virus-like particle platform, generated antibodies that bind to the pT181 tau epitope, a recognized Alzheimer's biomarker. Plans are underway to advance to Phase 1 human ...

Authors constructed a novel HSV-based therapeutic vaccine to cure SIV in a primate model. The novel HSV vector is deleted for ICP34.5. Evidence is given that this protein blocks HIV reactivation by ...

It is a non-replicating adenovirus vector-based therapy containing the gene interferon alfa-2b, administered locally as a monotherapy by catheter directly into the bladder once every three months.